| UniProt ID | JADE2_HUMAN | |
|---|---|---|
| UniProt AC | Q9NQC1 | |
| Protein Name | E3 ubiquitin-protein ligase Jade-2 {ECO:0000303|PubMed:25018020} | |
| Gene Name | JADE2 | |
| Organism | Homo sapiens (Human). | |
| Sequence Length | 790 | |
| Subcellular Localization | ||
| Protein Description | Component of the HBO1 complex which has a histone H4-specific acetyltransferase activity, a reduced activity toward histone H3 and is responsible for the bulk of histone H4 acetylation in vivo. [PubMed: 16387653 Acts as a E3 ubiquitin-protein ligase mediating the ubiquitination and subsequent proteasomal degradation of target protein histone demethylase KDM1A] | |
| Protein Sequence | MEEKRRKYSISSDNSDTTDSHATSTSASRCSKLPSSTKSGWPRQNEKKPSEVFRTDLITAMKIPDSYQLSPDDYYILADPWRQEWEKGVQVPAGAEAIPEPVVRILPPLEGPPAQASPSSTMLGEGSQPDWPGGSRYDLDEIDAYWLELINSELKEMERPELDELTLERVLEELETLCHQNMARAIETQEGLGIEYDEDVVCDVCRSPEGEDGNEMVFCDKCNVCVHQACYGILKVPTGSWLCRTCALGVQPKCLLCPKRGGALKPTRSGTKWVHVSCALWIPEVSIGCPEKMEPITKISHIPASRWALSCSLCKECTGTCIQCSMPSCVTAFHVTCAFDHGLEMRTILADNDEVKFKSFCQEHSDGGPRNEPTSEPTEPSQAGEDLEKVTLRKQRLQQLEEDFYELVEPAEVAERLDLAEALVDFIYQYWKLKRKANANQPLLTPKTDEVDNLAQQEQDVLYRRLKLFTHLRQDLERVRNLCYMVTRRERTKHAICKLQEQIFHLQMKLIEQDLCRGLSTSFPIDGTFFNSWLAQSVQITAENMAMSEWPLNNGHREDPAPGLLSEELLQDEETLLSFMRDPSLRPGDPARKARGRTRLPAKKKPPPPPPQDGPGSRTTPDKAPKKTWGQDAGSGKGGQGPPTRKPPRRTSSHLPSSPAAGDCPILATPESPPPLAPETPDEAASVAADSDVQVPGPAASPKPLGRLRPPRESKVTRRLPGARPDAGMGPPSAVAERPKVSLHFDTETDGYFSDGEMSDSDVEAEDGGVQRGPREAGAEEVVRMGVLAS | |
| Overview of Protein Modification Sites with Functional and Structural Information | ||
|
|
||
* ASA = Accessible Surface Area
| Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
|---|---|---|---|---|---|
| 8 | Phosphorylation | MEEKRRKYSISSDNS CCHHHHCCCCCCCCC | 14.93 | 23663014 | |
| 9 | Phosphorylation | EEKRRKYSISSDNSD CHHHHCCCCCCCCCC | 21.01 | 23401153 | |
| 11 (in isoform 3) | Phosphorylation | - | 26.21 | 21406692 | |
| 11 | Phosphorylation | KRRKYSISSDNSDTT HHHCCCCCCCCCCCC | 26.21 | 25159151 | |
| 12 (in isoform 3) | Phosphorylation | - | 38.86 | 21406692 | |
| 12 | Phosphorylation | RRKYSISSDNSDTTD HHCCCCCCCCCCCCC | 38.86 | 25159151 | |
| 15 (in isoform 3) | Phosphorylation | - | 41.13 | 21406692 | |
| 15 | Phosphorylation | YSISSDNSDTTDSHA CCCCCCCCCCCCCCC | 41.13 | 25159151 | |
| 17 | Phosphorylation | ISSDNSDTTDSHATS CCCCCCCCCCCCCCC | 32.12 | 23663014 | |
| 18 | Phosphorylation | SSDNSDTTDSHATST CCCCCCCCCCCCCCC | 40.26 | 23663014 | |
| 20 | Phosphorylation | DNSDTTDSHATSTSA CCCCCCCCCCCCCCH | 16.96 | 23663014 | |
| 23 | Phosphorylation | DTTDSHATSTSASRC CCCCCCCCCCCHHHH | 27.41 | 30108239 | |
| 24 | Phosphorylation | TTDSHATSTSASRCS CCCCCCCCCCHHHHH | 22.58 | 30108239 | |
| 25 | Phosphorylation | TDSHATSTSASRCSK CCCCCCCCCHHHHHC | 24.77 | 30108239 | |
| 26 | Phosphorylation | DSHATSTSASRCSKL CCCCCCCCHHHHHCC | 24.82 | 30108239 | |
| 28 | Phosphorylation | HATSTSASRCSKLPS CCCCCCHHHHHCCCC | 33.32 | 30108239 | |
| 31 | Phosphorylation | STSASRCSKLPSSTK CCCHHHHHCCCCCCC | 35.80 | 16674116 | |
| 32 (in isoform 3) | Acetylation | - | 68.96 | - | |
| 32 | Acetylation | TSASRCSKLPSSTKS CCHHHHHCCCCCCCC | 68.96 | 19608861 | |
| 38 | Acetylation | SKLPSSTKSGWPRQN HCCCCCCCCCCCCCC | 49.25 | 19608861 | |
| 75 | Phosphorylation | QLSPDDYYILADPWR CCCCCCEEEEECHHH | 9.10 | 28387310 | |
| 117 | Phosphorylation | EGPPAQASPSSTMLG CCCCCCCCCCCCCCC | 17.15 | 25850435 | |
| 119 | Phosphorylation | PPAQASPSSTMLGEG CCCCCCCCCCCCCCC | 35.63 | 25850435 | |
| 120 | Phosphorylation | PAQASPSSTMLGEGS CCCCCCCCCCCCCCC | 22.63 | 26657352 | |
| 121 | Phosphorylation | AQASPSSTMLGEGSQ CCCCCCCCCCCCCCC | 22.28 | 25850435 | |
| 127 | Phosphorylation | STMLGEGSQPDWPGG CCCCCCCCCCCCCCC | 33.95 | 25850435 | |
| 135 | Phosphorylation | QPDWPGGSRYDLDEI CCCCCCCCCCCHHHH | 33.31 | 28176443 | |
| 253 | Ubiquitination | CALGVQPKCLLCPKR HHCCCCCCEEECCCC | 22.03 | - | |
| 259 | Acetylation | PKCLLCPKRGGALKP CCEEECCCCCCCCCC | 63.78 | 25953088 | |
| 292 | Acetylation | VSIGCPEKMEPITKI CCCCCCCCCCCCCEE | 33.43 | 26051181 | |
| 298 | Acetylation | EKMEPITKISHIPAS CCCCCCCEECCCCHH | 42.82 | 19608861 | |
| 318 | Phosphorylation | CSLCKECTGTCIQCS CCCCHHHHCCEEECC | 36.30 | 24719451 | |
| 336 | Phosphorylation | CVTAFHVTCAFDHGL CEEEEEHHHHHCCCC | 6.91 | 24719451 | |
| 356 | Ubiquitination | LADNDEVKFKSFCQE EECCCCEEEHHHHHH | 45.05 | - | |
| 358 | Ubiquitination | DNDEVKFKSFCQEHS CCCCEEEHHHHHHCC | 36.58 | - | |
| 374 | Phosphorylation | GGPRNEPTSEPTEPS CCCCCCCCCCCCCHH | 39.27 | - | |
| 381 | Phosphorylation | TSEPTEPSQAGEDLE CCCCCCHHHCCCCHH | 26.82 | 26714015 | |
| 389 | Ubiquitination | QAGEDLEKVTLRKQR HCCCCHHHHHHHHHH | 48.06 | - | |
| 391 | Phosphorylation | GEDLEKVTLRKQRLQ CCCHHHHHHHHHHHH | 31.73 | - | |
| 445 | Phosphorylation | NANQPLLTPKTDEVD CCCCCCCCCCCHHHH | 30.35 | 20068231 | |
| 447 | Ubiquitination | NQPLLTPKTDEVDNL CCCCCCCCCHHHHHH | 64.47 | - | |
| 448 | Phosphorylation | QPLLTPKTDEVDNLA CCCCCCCCHHHHHHH | 38.30 | - | |
| 467 | Acetylation | DVLYRRLKLFTHLRQ HHHHHHHHHHHHHHH | 39.48 | 26051181 | |
| 470 | Phosphorylation | YRRLKLFTHLRQDLE HHHHHHHHHHHHHHH | 30.36 | 20068231 | |
| 484 | Phosphorylation | ERVRNLCYMVTRRER HHHHHHHHHHHCHHH | 9.59 | - | |
| 498 | Acetylation | RTKHAICKLQEQIFH HHHHHHHHHHHHHHH | 47.28 | 26051181 | |
| 603 | Acetylation | GRTRLPAKKKPPPPP CCCCCCCCCCCCCCC | 60.43 | 25953088 | |
| 617 | Phosphorylation | PPQDGPGSRTTPDKA CCCCCCCCCCCCCCC | 29.59 | 30576142 | |
| 619 | Phosphorylation | QDGPGSRTTPDKAPK CCCCCCCCCCCCCCC | 44.36 | 25627689 | |
| 620 | Phosphorylation | DGPGSRTTPDKAPKK CCCCCCCCCCCCCCC | 28.51 | 28176443 | |
| 635 | Phosphorylation | TWGQDAGSGKGGQGP CCCCCCCCCCCCCCC | 38.77 | 25159151 | |
| 637 | Acetylation | GQDAGSGKGGQGPPT CCCCCCCCCCCCCCC | 62.66 | 25953088 | |
| 652 | Phosphorylation | RKPPRRTSSHLPSSP CCCCCCCCCCCCCCC | 17.60 | 21552520 | |
| 657 | Phosphorylation | RTSSHLPSSPAAGDC CCCCCCCCCCCCCCC | 56.14 | 21552520 | |
| 733 | Phosphorylation | DAGMGPPSAVAERPK CCCCCCCHHHHCCCC | 38.21 | 28555341 | |
| 747 | Phosphorylation | KVSLHFDTETDGYFS CEEEEEECCCCCCCC | 39.58 | 30576142 | |
| 754 | Phosphorylation | TETDGYFSDGEMSDS CCCCCCCCCCCCCCC | 35.90 | 30576142 | |
| 761 | Phosphorylation | SDGEMSDSDVEAEDG CCCCCCCCCCCCCCC | 35.93 | 30576142 |
| Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
|---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of JADE2_HUMAN !! | ||||||
| Modified Location | Modified Residue | Modification | Function | Reference | ||
|---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of JADE2_HUMAN !! | ||||||
* Distance = the distance between SAP position and PTM sites.
| Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
|---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of JADE2_HUMAN !! | ||||||
| Kegg Disease | ||||||
|---|---|---|---|---|---|---|
| There are no disease associations of PTM sites. | ||||||
| OMIM Disease | ||||||
| There are no disease associations of PTM sites. | ||||||
| Kegg Drug | ||||||
| There are no disease associations of PTM sites. | ||||||
| DrugBank | ||||||
| There are no disease associations of PTM sites. | ||||||
loading...
| Acetylation | |
| Reference | PubMed |
| "Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-32; LYS-38 AND LYS-298, ANDMASS SPECTROMETRY. | |
| "Substrate and functional diversity of lysine acetylation revealed bya proteomics survey."; Kim S.C., Sprung R., Chen Y., Xu Y., Ball H., Pei J., Cheng T.,Kho Y., Xiao H., Xiao L., Grishin N.V., White M., Yang X.-J., Zhao Y.; Mol. Cell 23:607-618(2006). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-32 AND LYS-38, AND MASSSPECTROMETRY. | |